New sensor aims to predict heart failure readmissions without needles
NCT ID NCT07671742
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is testing a non-invasive device that uses sensors placed on the chest to monitor heart failure patients during their hospital stay and for 90 days after discharge. The goal is to see if the device's measurements can help predict which patients are at higher risk of being readmitted or dying. The study involves 1,000 adults hospitalized for heart failure and does not change their medical care.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this could lead to a simple, non-invasive way to monitor heart failure patients and predict who is at risk of readmission or death after hospitalization.
What could go wrong
This is an observational study, not a treatment trial. The device is not being tested to improve outcomes, only to see if its measurements relate to patient health. Results may not lead to any new device or change in care.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEART FAILURE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Skåne University Hospital
RECRUITINGLund, Sweden
Contact Phone: •••-•••-•••• Email: •••••@•••••